Cho Research Lab


We are a team of researchers dedicated to developing conventional & novel drug delivery systems that enhance image-guided surgical accuracy and drug/cosmetic treatment efficacy.

Professor of Pharmaceutical Sciences &
Executive Director, Health Innovation and Strategy
College of Pharmacy and Health Sciences
Fairleigh Dickinson University
Ph.D. University of Wisconsin-Madison
M.S. Sookmyung Women's University, Korea
B.Pharm. Sookmyung Women's University, Korea
E-mail: hyunahc@fdu.edu

We focus on developing and characterizing advanced drug delivery systems that improve "drug deliverability" and therapeutic/diagnostic efficacies.

We successfully prepared Fibronectin CS1 peptide-conjugated poly(ethylene glycol)-block-poly(D, L-lactic acid) (FibCS1-PEG-b-PLA) micelles carrying Rapa, which were 98.08 ± 1.15 nm in particle size with a polydispersity index of 0.21 ± 0.01. In this study, we highlighted the feasibility of short-term intranasal administration of brain-targeting micelles carrying Rapa for improving cognitive behavior including motor coordination, recognition memory, and special learning and memory in an AD-bearing mouse model.

Nano-based NIR fluorescence imaging for better tumor delineation has been established as a powerful tool to give surgeons real-time information about the location and margin of the tumor region by compensating the depth limitation.

The nanogel pellet are shown to be stable as a pellet at ambient temperature, absorb water and change to a gel formulation at physiological temperature, and achieve gradual long-term release of the payloads. The in vivo testing in an orthotopic rodent models has shown an acceptable safety profile when implanted intracranially and a significant improvement in overall survival.

We aim to use a desktop FDM-based 3D printer to prototype portable medicine containers in a blister packet appearance with auxiliary braille flags that help validate early concepts and facilitate the conversation on refining product features in a rapid and affordable manner.
Sugandhi VV, Gattu K, Mundrathi V, Khairnar R, Arshad T, Kumar S, Cho H. Intranasal delivery of rapamycin via brain-targeting polymeric micelles for Alzheimer's disease treatment. Int J Pharm. 2025 Oct 15;683:126011. doi: 10.1016/j.ijpharm.2025.126011. Epub 2025 Aug 6. PMID: 40780467; PMCID: PMC12372931.
Arshad T, Mundrathi V, Perez VE, Nunez JM, Cho H. Topical Probiotic Hydrogels for Burn Wound Healing. Gels. 2024; 10(9):545. https://doi.org/10.3390/gels10090545
Cho, H., Kang, S., Zhao, K., Sugandhi, V. and Melissinos, G. (2024), "Prototyping of portable medicine containers with embossed braille using an affordable desktop 3D printer", Rapid Prototyping Journal, Vol. 30 No. 7, pp. 1301-1312. https://doi.org/10.1108/RPJ-01-2024-0026
Rahman S, Haque TN, Sugandhi VV, Saraswat AL, Xin X, Cho H. Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment. Pharm Res. 2023;40(10):2291-2301. doi:10.1007/s11095-023-03506-z
Dr. Hyunah Cho's Startup, Spill Essentials LLC, received the 3rd Prize at the Idea Pitch Competition, UKC 2025.
Dr. Hyunah Cho's Startup, Spill Essentials LLC, successfully completed NSF I-Corps Nationals!
Dr. Hyunah Cho, Ph.D., an Assistant Professor, department of Pharmaceutical Sciences has been awarded a $750,000 R16 Sure-First grant from the National Institute of General Medical Sciences (NIGMS), a division of the National Institute of Health (NIH).
https://www.linkedin.com/feed/update/urn:li:activity:7234926641519497216/
Summer interns 2024
@ Edmund Gan, Camellia Teng, Simon Kang
1/5
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.